Negative Pressure Wound Therapy Devices Market Size, Share & Trends Analysis Report By Product (Conventional NPWT Devices, Single-use NPWT Devices), By Applications (Chronic Wounds, Acute Wounds), By End-User (Hospitals and Clinics, Ambulatory Surgery Centers (ASCs), Home Care Settings) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Market Overview

The negative pressure wound therapy devices market size was valued at USD 2,540.20 million in 2022. It is projected to reach USD 4,219.29 million by 2031, growing at a CAGR of 5.80% during the forecast period (2023-2031). 

NPWT, also known as vacuum-assisted wound closure therapy, uses sub-atmospheric pressure to promote the healing of fresh and old wounds. NPWT devices can be found in various sizes and shapes to accommodate a wide range of patient body types and degrees of injury. These tools, which consist of a vacuum pump, drainage tubing, and a dressing set, improve patients' health by speeding up the healing process, decreasing the frequency with which dressings must be changed, and providing a more practical solution for dealing with the aftermath of closed surgical incisions. The rising prevalence of chronic diseases like diabetes and obesity and the maturing of the global population bodes well for the future of the negative pressure wound therapy device market.

Highlights

• The conventional NPWT Devices segment is the highest contributor to the market by product. 
• The chronic wounds segment is the highest contributor to the market by application.
• The hospitals and clinics segment is the highest contributor to the market by end-user.
• North America is the most significant revenue contributor by region.

Market Dynamics

Global negative pressure wound therapy devices market drivers:

Quickly aging population and favorable demographics globally

Over the past few years, the global geriatric population has considerably increased. They are susceptible to several chronic illnesses, including arthritis, cancer, type 2 diabetes, obesity, and cardiovascular diseases. Furthermore, certain conditions, like stomach cancer, are more common in older persons. As a result, NPWT devices are necessary to treat ulcers caused by long-term medical problems like diabetes. Similar to how chronic diseases like cancer, arthritis, and cardiovascular disease require surgical therapy that involves incisions. Due to the significant risk of surgical site infections associated with these incisions, NPWT devices are needed. Thus, the substantial increase in the senior population worldwide is a key factor driving the market for negative pressure wound therapy devices.

Global negative pressure wound therapy devices market restraint:

Unnoticed side effects of npwt 

Although NPWT devices are an excellent alternative for treating acute and chronic wounds, multiple injuries and fatalities have been linked to their use. For instance, the FDA received reports of 6 deaths and 77 injury cases in 2009 as a result of the usage of NPWT devices, with the majority of the fatalities taking place in long-term care facilities. This was explained by the development of open wound infection and dressing fragments that remained in the wound. Additionally, the FDA published a list of contraindications for specific wound types, including exposed nerves, exposed anastomotic sites, non-enteric and undiscovered fistulas, and cancer in the wound, for which the use of NPWT devices should be avoided.

Global negative pressure wound therapy devices market opportunities:

Unmet wound care requirements

Given that wound care is a rising clinical field, the market for it has significant NPWT market growth potential. Additionally, there is a sizable unmet demand in this clinical domain due to the increase in acute and chronic wounds worldwide, which drives the market for negative pressure wound therapy devices. Additionally, more clinical practices being taught in medical schools, better care coordination between therapies and locations of care, and improved decision tools and standards for NPWT devices are all anticipated to create several prospects for market expansion in the future.

Regional Analysis

The global negative pressure wound therapy devices industry is divided into four regions: North America, Europe, Asia-Pacific, and LAMEA. 

North america dominates the global market

North America is the most significant revenue contributor and is expected to grow at a CAGR of 4.50% during the forecast period. The report has examined three influential North American nations: the United States, Canada, and Mexico. The United States, a mature market, contributed the most revenue to North America in 2019. This is explained by the fact that there have been more cases of chronic sores, including foot ulcers, leg ulcers, and atrial ulcers, in the area due to various medical issues. The American Medical Association and JAMA network estimate that in 2018, 4.5 million Americans suffered from chronic wounds. Due to rising healthcare expenses, an aging population in the United States, and an increase in the prevalence of diabetes and obesity globally, the burden of treating chronic wounds is rapidly increasing.

Europe is expected to go up at a CAGR of 5.90% during the forecast period. Germany, France, the U.K., Italy, Spain, and the rest of Europe are all included in the analysis of the European NPWT device market. The second-largest market for NPWT devices has proved to be Europe. While developed European nations like Germany, France, and Italy are anticipated to grow steadily, other countries like the U.K. and Spain are expected to expand rapidly throughout the prediction period. 

Japan, China, India, Australia, South Korea, and the rest of Asia-Pacific are all included in the analysis of the region. Asia-Pacific represents a viable market for NPWT devices because of its large population, high disposable income, and growing patient awareness of cutting-edge wound care solutions. Asia-Pacific has become a likely market for NPWT devices thanks to technology improvements and medical tourism, among other factors. Additionally, the majority of Asia-Pacific nations (including Australia, India, and Korea) have high rates of diabetes, which raises the risk of diabetic foot ulcers. Foot ulcers are one of the significant consequences that can result from poorly managed diabetes. As a result, as the number of diabetes cases rises, so does the chance of developing diabetic foot ulcers, which in turn drives up demand for NPWT devices.

Latin America, the Middle East, and Africa are known as LAMEA. Brazil, Saudi Arabia, South Africa, and the rest of LAMEA are all researched. In the global market for negative pressure wound therapy devices in 2019, it held a NPWT market share of 11.10% and is predicted to develop rapidly. The market for NPWT devices is still in its infancy because few facilities in LAMEA offer cutting-edge medical procedures and a shortage of qualified medical personnel. 

Segmental Analysis

The global negative pressure wound therapy devices industry is segmented by product, application, and end-user industry.

Based on product, the global negative pressure wound therapy devices market is bifurcated into Conventional NPWT Devices and Single-use NPWT Devices.

The conventional NPWT devices segment is the highest contributor to the market and is estimated to grow at a CAGR of 5.50% during the forecast period. The initial NPWT devices on the market were conventional NPWT systems. They are traditional care of wound systems that integrate negative pressure wound therapy with wound care technology. They consist of a pump, dispensable bandages, and exudate collection canisters. Additionally, these tools are typically employed for in-patients and are frequently powered by a primary electricity source. These devices can, however, also be modified for usage with outpatients. Additionally, depending on the clinical situation, these can administer up to -125 mmHg of pressure or possibly more to treat a variety of wounds, particularly those with many exudates.

Single-use systems are disposable NPWT devices designed to treat small- to medium-sized wounds with low to moderate exudate levels. They combine the advantages of NPWT with advanced wound care dressing. They are used for patients with various clinical situations, including managing incisions and lower extremity ulcers, flaps, pressure ulcers, grafts, and dehisced wounds. Additionally, some of these gadgets are mechanically driven and canister-free. Therefore, evaporation from the dressing's outer layer is the primary method for controlling fluid or exudate. Additionally, these devices are used in outpatient care because they are mechanically propelled and capable of handling mild to moderate exudate. These gadgets also include a little pump, eliminating the requirement for a large canister.

Based on application, the global negative pressure wound therapy devices market is bifurcated into chronic and acute wounds.

The chronic wounds segment is the highest contributor to the market and is estimated to grow at a CAGR of 6.30% during the forecast period. The market for negative pressure wound therapy devices is further segmented by kind, including pressure ulcers, diabetic foot ulcers, venous leg ulcers, and arterial ulcers. Additionally, it becomes chronic when an acute wound doesn't heal within three months. This is linked to the absence of one or more conditions necessary for healing, such as an environment free of infections and a sufficient supply of nutrients, oxygen, and blood. An ulcer, which is the disintegration of tissue, muscle, or bone, is the most prevalent type of chronic wound. Leg ulcers are commonplace in the elderly population. Most lower extremity ulcerations, or almost 80% of all cases, are venous ulcers, usually affecting older adults.

Any harm to the skin and underlying tissues resulting from an injury is a wound. At the same time, a wound is considered acute when it heals quickly and predictably. Additionally, the market for negative pressure wound therapy devices is further segmented into sub-segments by kind, including burns and trauma and surgical wounds. These wounds, ranging from tiny scratches to severe injuries, are external and can harm muscles, blood vessels, nerves, or other body organs. They are among the most common wounds, affecting many people worldwide. Toddlers and active adults are more likely to sustain an acute traumatic wound, whether small or severe, whereas older adults and those with delicate skin are more likely to sustain skin tears and abrasions.

Based on the end-user industry, the global negative pressure wound therapy devices market is bifurcated into Hospitals and Clinics, Ambulatory Surgery Centers (ASCs), and Home Care Settings.

The Hospitals and Clinics segment is the highest contributor to the market and is estimated to grow at a CAGR of 5.20% during the forecast period. Hospitals and clinics commonly see patients with gangrene, burns, cuts, and open wounds. As NPWT devices provide superior skin transplant healing, they are widely used in hospitals and clinics. Additionally, they promote improved wound healing in patients with diabetes mellitus and gangrene, which could otherwise result in amputation, and they aid in preventing infections in patients with wounds caused by orthopedic trauma or open fractures. Applications of NPWT devices allow for early hospital discharge, reduced surgical necessity, and simple hospital-to-lower-cost healthcare setting transfers.

Ambulatory surgery centers (ASC), commonly referred to as outpatient surgery centers or same-day surgery centers, are hospitals where surgical procedures are carried out without necessitating an overnight hospital stay. These healthcare facilities must have NPWT systems because they also treat trauma victims. In addition, factors supporting this market's expansion include an increase in awareness of ASC as a high-quality, cost-effective alternative to hospital-based care. Numerous NPWT devices are used in ambulatory surgery. Additionally, other factors, including the increase in ASCs worldwide, also help the market grow.

As this is a comparatively noninvasive treatment method, many wounds undergoing NPWT can be managed at home by a visiting home healthcare professional. For example, diabetic foot ulcers and chronic wounds with mixed etiologies, such as venous leg ulcers, arterial leg ulcers, and chronic wounds, can be treated at home. The transfer from acute care to home care settings is simple with NPWT. The primary driver of the deployment of NPWT devices in the home care market is the implementation of reimbursement policies for those settings. For instance, Medicare Part B reimbursement requirements apply to NPWT products made by Acelity. Like Medicare reimbursement rates in the United States, numerous private insurance companies offer coverage.

Recent Developments

• January 2022- A new use for the PICO 7 and PICO 14 single-use negative pressure wound care systems was unveiled by Smith and Nephew. The US Food and Drug Administration (FDA) approved the plans for use on closed surgical incisions to help lower the occurrence of wounds.
• August 2022- M Health Care's Medical Solutions Division advanced the delivery of 3M™ Veraflo™ Therapy. A new 3M™ Veraflo™ Cleanse Choice Complete™ Dressing Kit and a software upgrade for the 3M™ V.A.C.® Ulta Therapy Unit were introduced at no increased cost to the customer